352 related articles for article (PubMed ID: 28544152)
1. A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.
Piñana JL; Hernández-Boluda JC; Calabuig M; Ballester I; Marín M; Madrid S; Teruel A; Terol MJ; Navarro D; Solano C
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544152
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
3. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
4. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
5. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
7. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
8. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
[TBL] [Abstract][Full Text] [Related]
9. Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation.
Stamouli M; Tsonis I; Gkirkas K; Economopoulou C; Siafakas N; Pournaras S; Antoniadou A; Chondropoulos S; Karagiannidi A; Meletiadis J; Gigantes S; Baltadakis I; Goussetis E; Karakasis D; Tsirigotis P
Bone Marrow Transplant; 2021 Feb; 56(2):511-513. PubMed ID: 32772044
[No Abstract] [Full Text] [Related]
10. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
13. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
[TBL] [Abstract][Full Text] [Related]
14. Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.
Casey J; Morris K; Narayana M; Nakagaki M; Kennedy GA
Bone Marrow Transplant; 2013 Nov; 48(12):1558-61. PubMed ID: 23912665
[TBL] [Abstract][Full Text] [Related]
15. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR
Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
[TBL] [Abstract][Full Text] [Related]
16. Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants.
Schleuning M; Buxbaum-Conradi H; Jäger G; Kolb HJ
Hematol J; 2004; 5(2):135-44. PubMed ID: 15048064
[TBL] [Abstract][Full Text] [Related]
17. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience.
Nichols WG; Gooley T; Boeckh M
Biol Blood Marrow Transplant; 2001; 7 Suppl():11S-15S. PubMed ID: 11777098
[TBL] [Abstract][Full Text] [Related]
18. Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients.
Molinos-Quintana A; Pérez-de Soto C; Gómez-Rosa M; Pérez-Simón JA; Pérez-Hurtado JM
Bone Marrow Transplant; 2013 Feb; 48(2):265-8. PubMed ID: 23000643
[TBL] [Abstract][Full Text] [Related]
19. Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective study.
Atilla E; Sahin D; Atilla PA; Dolapci I; Tekeli A; Bozdag SC; Yuksel MK; Toprak SK; Ilhan O; Arslan O; Ozcan M; Gurman G; Topcuoglu P
Antivir Ther; 2018; 23(6):523-527. PubMed ID: 29424696
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
McCurdy LH; Milstone A; Dummer S
J Heart Lung Transplant; 2003 Jul; 22(7):745-53. PubMed ID: 12873542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
